Access Pathway Genomics Stock and Financial Details

Q: Can you buy Pathway Genomics stock?

You can no longer buy Pathway Genomicsstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Enterprise Value

Access valuation and stock price for companies like Pathway Genomics before its M&A.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Pathway Genomics stock FAQs

Can you buy Pathway Genomics stock?

You can no longer buy Pathway Genomics stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Pathway Genomics stock?

To invest in a private company like Pathway Genomics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Pathway Genomics stock?

You can no longer sell stock of Pathway Genomics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Pathway Genomics stock?

If you hold private company shares of Pathway Genomics - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Pathway Genomics stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Pathway Genomics a public company?

No, Pathway Genomics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Kamal Adawi

CFO

K'Lene Oen

Chief Business Officer

Nilesh Dharajiya MD

Chief Laboratory Officer & Medical Director

James Plante

Founder, Board Member, CEO

Glenn Braunstein MD

Chief Medical Officer

Anja Kammesheidt Ph.D

Chief Scientific Officer

Michael Nova Ph.D

Chief Innovation Officer

Board Members

Christopher Kitching

Mark Sopp

Pathway Genomics

Peter Leddy Ph.D

Peter Pace

Tokens Journal 11/11/2018

Prostate Biopsy Market Size, Application,Revenue, Types, Trends in Future, Scope to 2021 - TokensJournal

The Prostate Biopsy Market report provides valuable and unique information which is very essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing company to mark themself over the market Prostate Biopsy market to grow at a CAGR OF 12.66% during the period 2017-2021. This …

Tokens Journal 11/11/2018

Direct-To-Consumer Genetic Testing Market with top 20 Countries data Forecast to 2022 with Global Key Companies Profile, Supply, Demand, Cost Structure and Growth Factors - TokensJournal

Direct-To-Consumer Genetic Testing Market Report cover detailed competitive outlook including the Direct-To-Consumer Genetic Testing Industry share and company profiles of the key participants operating in the global market. The Direct-To-Consumer Genetic Testing market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and …

Bitnews Today 10/27/2018

Direct-to-consumer Genetic Testing Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2023 - BitsEther

Direct-to-consumer Genetic Testing Market Research highlights key dynamics of Global Direct-to-consumer Genetic Testing Industry sector. The potential of the Direct-to-consumer Genetic Testing Market has been investigated along with the key challenges. The current Direct-to-consumer Genetic Testing Market scenario and future prospects of the sector has also been studied. Market Report provides additional information like Sales Channel, Distributors, Traders …

Bits Online 10/26/2018

Direct-To-Consumer Genetic Testing Market To See A Huge Production Growth & Business Opportunities During 2017-2021 - BittAsset

The Direct-To-Consumer Genetic Testing Market Report provides Growth history, Sales channel, Manufacturers profiled in Direct-To-Consumer Genetic Testing industry, Market share of product and scope of a Region in detail. The Market report also consists key Drivers and limiting factors affect the Direct-To-Consumer Genetic Testing Market Growth, Change in industry Trends or challenges faced by Direct-To-Consumer …

Pathway Genomics Stock

Register To Buy and Sell Private Company Shares